SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

Toshiba and Johns Hopkins join forces over big data Leveraging big data to improve outcomes

New MR technique offers new insight into multiple sclerosis May help improve treatment monitoring

Is it time to be anti-antibiotics? The cost of over-prescribed antibiotics goes far beyond funds

MEDICA 2014: new imaging technology improves breast cancer diagnosis Shows structures that mammo can't

Iodine-based contrast for CT safe for most patients Goes against the previous notion

September's New Product Showcase This month's roundup of the latest industry products.

Information portal will reveal cost and quality of health care services HCCI works with insurance companies to create it

Researchers unveil non-invasive prostate screening technique Predicts prostate cancer with 98.1 percent accuracy

FDA approves GE's SenoClaire Sharper images and no increase in dose

Study finds CT lung cancer screening to be cost effective in saving lives The ACR says it's time for Medicare to cover high-risk individuals

George Morgan is vRad's new CEO.

vRad names US Oncology exec CEO

by Brendon Nafziger , DOTmed News Associate Editor
Virtual Radiologic, the country's biggest teleradiology provider, named former US Oncology executive George Morgan its new CEO.

vRad said that starting Tuesday Morgan would step in for departing CEO and president Rob Kill.

Morgan spent the last seven years as chief operating officer with US Oncology, a network of more than 1,000 cancer doctors that was bought by McKesson in 2010. During his tenure, the company's revenues doubled, growing from $1.5 billion to $3 billion, vRad said.

Before joining US Oncology, Morgan led the ambulatory surgical division of the Hospital Corporation of America, vRad said.

vRad runs a network of more than 400 radiologists and also makes workflow and image sharing and storing software. Over the past few years, it has grown quickly, having bought rival teleradiology provider Nighthawk in late 2010.

vRad's outgoing CEO Kill was with the company for five years. His LinkedIn page lists his current position as a board member on an audit committee of Uroplasty Inc., a company that makes neuromodulation products to stop incontinence.
Story Continues Below Advertisement

We want to buy your Siemens Symphony or Avanto MRI -- today!

Top Dollar Paid, Fixed or Mobile. Call our Siemens Specialist for a Quote today -- 212-558-6600 Ext. 250 DOTmed Certified



"George is a highly experienced and talented leader who will help vRad achieve its next stage of growth," Eran Broshy, chair of vRad's board of directors, and a senior advisor with the company's primary sponsor, Providence Equity Partners, said in a statement. "We also thank Rob Kill...for his leadership in successfully transitioning vRad from a niche teleradiology provider to the strong market leader it is today."

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED